|
Last month the FDA (Food and Drug Administration) voted unanimously that the benefit of Advair and Symbicort outweighed the risks of adverse effects in adults. This, following concerns about reports of adverse effects, even death, associated with these inhalers.
That's great news for the people who take these medicines and are breathing much better because of it. It's comforting news for people with asthma, but what about those with...
|
Write a comment:
|